SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 578.94 |
| Enterprise Value ($M) | 325.74 |
| Book Value ($M) | 145.13 |
| Book Value / Share | 2.92 |
| Price / Book | 3.99 |
| NCAV ($M) | 136.49 |
| NCAV / Share | 2.75 |
| Price / NCAV | 4.24 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.70 |
| Return on Assets (ROA) | -1.54 |
| Return on Equity (ROE) | -1.99 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 10.44 |
| Current Ratio | 10.44 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 267.36 |
| Assets | 275.99 |
| Liabilities | 130.87 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Capital World Investors | 6.40 | -5.82 | |
| 13G | Vestal Point Capital, LP | 9.30 | ||
| 13G/A | Suvretta Capital Management, Llc | 9.99 | 61.29 | |
| 13G/A | Tang Capital Management Llc | 9.99 | ||
| 13G/A | Adage Capital Management, L.P. | 3.29 | ||
| 13G/A | Vanguard Group Inc | 4.97 | 0.00 | |
| 13D/A | Frazier Life Sciences Public Fund, L.P. | 10.00 | 32.54 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 82,407 | 388,094 | 21.23 | |
| 63,652 | 359,854 | 17.69 | |
| 59,258 | 319,076 | 18.57 | |
| 101,012 | 469,331 | 21.52 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IVVD – Invivyd, Inc. | IXHL – Incannex Healthcare Inc. |
| JANX – Janux Therapeutics, Inc. | KLTO – Klotho Neurosciences, Inc. |
| KOD – Kodiak Sciences Inc. |
Financial data and stock pages provided by
Fintel.io